Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis despite chronic azithromycin therapy

J Cyst Fibros. 2021 May;20(3):555-557. doi: 10.1016/j.jcf.2020.09.004. Epub 2020 Sep 16.
No abstract available

Keywords: Azithromycin; Drug resistance; Macrolide; Mycobacterium avium complex (MAC); Nontuberculous mycobacteria.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Azithromycin / administration & dosage
  • Azithromycin / therapeutic use*
  • Child
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis / microbiology*
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Mycobacterium avium Complex
  • Mycobacterium avium-intracellulare Infection / drug therapy*
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Azithromycin